MENU
BBIO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

BridgeBio Pharma (BBIO) Earnings Date & Reports

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases... Show more

A.I. Advisor
published Earnings

BBIO is expected to report earnings to fall 23.12% to -73 cents per share on February 19

BridgeBio Pharma BBIO Stock Earnings Reports
Q4'25
Est.
$-0.73
Q3'25
Missed
by $0.07
Q2'25
Missed
by $0.20
Q1'25
Beat
by $0.03
Q4'24
Missed
by $0.27
The last earnings report on October 29 showed earnings per share of -94 cents, missing the estimate of -87 cents. With 1.77M shares outstanding, the current market capitalization sits at 12.54B.
View a ticker or compare two or three
BBIO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. BBIO showed earnings on October 29, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a company which engages in developing transformative medicines to treat patients who suffer from mendelian diseases.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
3160 Porter Drive
Phone
+1 650 391-9740
Employees
556
Web
https://www.bridgebio.com